Antibodies to Seasonal Coronaviruses Rarely Cross-React With SARS-CoV-2: Findings From an African Birth Cohort
- PMID: 34533491
- PMCID: PMC8575088
- DOI: 10.1097/INF.0000000000003325
Antibodies to Seasonal Coronaviruses Rarely Cross-React With SARS-CoV-2: Findings From an African Birth Cohort
Abstract
Antibodies to seasonal human-coronaviruses (sHCoV) may cross-protect against SARS-CoV-2. We investigated antibody responses in biobanked serum obtained before the pandemic from infants with polymerase chain reaction-confirmed sHCoV. Among 141 samples with antibodies to sHCoV, 4 (2.8%) were positive for SARS-CoV-2-S1 and 8 (5.7%) for SARS-CoV-2-S2. Antibodies to sHCoV rarely cross-react with SARS-CoV-2 antigens and are unlikely to account for mild pediatric illness.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Worldometers.info. Worldometer COVID-19 coronavirus data. Available at: https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/. Accessed June 26, 2021.
-
- Monthly COVID-19 in children. National Institute Communicable Diseases (NICD), South Africa. Available at: https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveil.... Accessed June 26, 2021.
-
- Braun J, Loyal L, Frentsch M, et al. . SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270–274. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
